#METABOLOMICS WORKBENCH yorch40_20201020_054228 DATATRACK_ID:2217 STUDY_ID:ST001518 ANALYSIS_ID:AN002521 PROJECT_ID:PR001023
VERSION             	1
CREATED_ON             	November 4, 2020, 10:24 am
#PROJECT
PR:PROJECT_TITLE                 	Metabolome analysis in the diagnosis of childhood cerebellar ataxia
PR:PROJECT_SUMMARY               	Metabolome studies to aid in the diagnosis and molecular elucidation of a child
PR:PROJECT_SUMMARY               	presenting chronic progressive cerebellar ataxia and an undiagnosed condition.
PR:INSTITUTE                     	CEMBIO
PR:LAST_NAME                     	Sáiz
PR:FIRST_NAME                    	Jorge
PR:ADDRESS                       	km 0, Universidad CEU-San Pablo Urbanización Montepríncipe, M-501, 28925
PR:ADDRESS                       	Alcorcón
PR:EMAIL                         	jorge.saizgalindo@ceu.es
PR:PHONE                         	0034913 72 47 11
#STUDY
ST:STUDY_TITLE                   	Metabolome analysis in the diagnosis of childhood cerebellar ataxia
ST:STUDY_SUMMARY                 	Metabolome studies to aid in the diagnosis and molecular elucidation of a child
ST:STUDY_SUMMARY                 	presenting chronic progressive cerebellar ataxia and an undiagnosed condition.
ST:INSTITUTE                     	CEMBIO
ST:LAST_NAME                     	Sáiz
ST:FIRST_NAME                    	Jorge
ST:ADDRESS                       	km 0, Universidad CEU-San Pablo Urbanización Montepríncipe. M-501, 28925
ST:ADDRESS                       	Alcorcón
ST:EMAIL                         	jorge.saizgalindo@ceu.es
ST:PHONE                         	913 72 47 11
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#FACTORS
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_LC_POS	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Plasma_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_LC_NEG	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Plasma_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_GC	Subject:Control	Technique=GC; RAW_FILE_NAME=Control_Plasma_GC
SUBJECT_SAMPLE_FACTORS           	-	Control_Plasma_CE	Subject:Control	Technique=CE; RAW_FILE_NAME=Control_Plasma_CE
SUBJECT_SAMPLE_FACTORS           	-	Control_Urine_LC_POS	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Urine_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Control_Urine_LC_NEG	Subject:Control	Technique=LC; RAW_FILE_NAME=Control_Urine_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Control_Urine_CE	Subject:Control	Technique=CE; RAW_FILE_NAME=Control_Urine_CE
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_LC_POS	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Plasma_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_LC_NEG	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Plasma_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_GC	Subject:Case	Technique=GC; RAW_FILE_NAME=Case_Plasma_GC
SUBJECT_SAMPLE_FACTORS           	-	Case_Plasma_CE	Subject:Case	Technique=CE; RAW_FILE_NAME=Case_Plasma_CE
SUBJECT_SAMPLE_FACTORS           	-	Case_Urine_LC_POS	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Urine_LC_POS
SUBJECT_SAMPLE_FACTORS           	-	Case_Urine_LC_NEG	Subject:Case	Technique=LC; RAW_FILE_NAME=Case_Urine_LC_NEG
SUBJECT_SAMPLE_FACTORS           	-	Case_Urine_CE	Subject:Case	Technique=CE; RAW_FILE_NAME=Case_Urine_CE
#COLLECTION
CO:COLLECTION_SUMMARY            	Metabolite extraction was performed in plasma and urine samples from the patient
CO:COLLECTION_SUMMARY            	and a healthy control, matched for age, sex and weight, according to standard
CO:COLLECTION_SUMMARY            	protocols with some modifications.
CO:SAMPLE_TYPE                   	Blood (plasma)
CO:STORAGE_CONDITIONS            	-80℃
#TREATMENT
TR:TREATMENT_SUMMARY             	Metabolite extraction was performed in plasma and urine samples from the patient
TR:TREATMENT_SUMMARY             	and a healthy control, matched for age, sex and weight, according to standard
TR:TREATMENT_SUMMARY             	protocols with some modifications.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	Plasma sample preparation for liquid chromatography–mass spectrometry
SP:SAMPLEPREP_SUMMARY            	(LC–MS) entailed the following steps: (1) thaw sample on ice, vortex for 2 min
SP:SAMPLEPREP_SUMMARY            	and transfer 100 µL of plasma into an Eppendorf tube; (2) for protein
SP:SAMPLEPREP_SUMMARY            	precipitation, add 300 µL of cold (-18˚C) methanol/ethanol (1:1 v/v), vortex
SP:SAMPLEPREP_SUMMARY            	for 1 min, incubate on ice for 5 min and vortex again briefly; (3) centrifuge at
SP:SAMPLEPREP_SUMMARY            	13000 rpm, 4˚C, for 20 min; and (4) transfer the supernatant into the LC–MS
SP:SAMPLEPREP_SUMMARY            	system. Plasma sample preparation for gas chromatography–mass spectrometry
SP:SAMPLEPREP_SUMMARY            	(GC–MS) entailed the following steps: (1) thaw sample on ice, vortex for 2 min
SP:SAMPLEPREP_SUMMARY            	and transfer 40 µL of plasma into an Eppendorf tube; (2) for protein
SP:SAMPLEPREP_SUMMARY            	precipitation, add 120 µL of cold acetonitrile, vortex for 2 min and incubate
SP:SAMPLEPREP_SUMMARY            	on ice for 5 min; (3) centrifuge at 15400 rpm, 4˚C, for 10 min; and (4)
SP:SAMPLEPREP_SUMMARY            	transfer the supernatant into a GC vial with insert; (5) evaporate in a Speedvac
SP:SAMPLEPREP_SUMMARY            	at 30°C until dry; (6) add 10 µL of O-methoxyamine hydrochloride (15 mg/mL) in
SP:SAMPLEPREP_SUMMARY            	pyridine and vortex for 5 min; (7) sonicate for 2 min and vortex for 2 min
SP:SAMPLEPREP_SUMMARY            	(repeat step a total of three times); (8) incubate at room temperature for 16 h
SP:SAMPLEPREP_SUMMARY            	in darkness for the reaction of the methoxymation; (9) add 10 µL of
SP:SAMPLEPREP_SUMMARY            	N,O-Bis(trimethylsilyl)trifluoroacetamide (BSTFA) with 1 % trimethylchlorosilane
SP:SAMPLEPREP_SUMMARY            	(TMCS) and incubate 1 h at 70 ˚C for the silylation; (10) add 100 µL of 10 ppm
SP:SAMPLEPREP_SUMMARY            	C18:0 methyl ester in n-heptane as internal standard, vortex for 2 min and
SP:SAMPLEPREP_SUMMARY            	centrifuge at 2500 rpm, 20˚C, for 15 min; and (11) transfer into the GC–MS
SP:SAMPLEPREP_SUMMARY            	system. Plasma sample preparation for capillary electrophoresis–mass
SP:SAMPLEPREP_SUMMARY            	spectrometry (CE–MS) entailed the following steps: (1) thaw sample on ice,
SP:SAMPLEPREP_SUMMARY            	vortex for 1 min and transfer 100 µL of plasma into an Eppendorf tube already
SP:SAMPLEPREP_SUMMARY            	filled with 100 µL of 0.2 M formic acid with 5 % acetonitrile and 0.4 mM
SP:SAMPLEPREP_SUMMARY            	methionine sulfone as internal standard; (2) vortex for 2 min and transfer to a
SP:SAMPLEPREP_SUMMARY            	Millipore filter (30 kDa protein cutoff); (3) centrifuge at 2000 rpm, 4˚C, for
SP:SAMPLEPREP_SUMMARY            	70 min; and (4) transfer the filtrate into a CE vial where the volume is
SP:SAMPLEPREP_SUMMARY            	directly injected into the CE–MS system. Urine samples for LC–MS were thawed
SP:SAMPLEPREP_SUMMARY            	on ice and vortexed prior injection into the LC-MS system (without
SP:SAMPLEPREP_SUMMARY            	pre-treatment). For CE–MS, sample procedure entailed: (1) thaw on ice and
SP:SAMPLEPREP_SUMMARY            	vortex for 1 min and transfer 200 µL into an Eppendorf tube; (2) centrifuge at
SP:SAMPLEPREP_SUMMARY            	13200 rpm, 4˚C, for 20 min; (3) transfer 100 µL of the supernatant into an
SP:SAMPLEPREP_SUMMARY            	Eppendorf tube already filled with 400 µL of 0.125 M formic acid with 0.25 mM
SP:SAMPLEPREP_SUMMARY            	methionine sulfone as internal standard; (4) vortex for 1 min and centrifuge at
SP:SAMPLEPREP_SUMMARY            	13200 rpm, 4˚C, for 10 min; and (5) transfer 200 µL of the supernatant into a
SP:SAMPLEPREP_SUMMARY            	CE vial where the volume is directly injected into the CE–MS system. Quality
SP:SAMPLEPREP_SUMMARY            	control (QC) samples were independently prepared for each technique and followed
SP:SAMPLEPREP_SUMMARY            	the same procedure as applied for experimental samples. QC samples were always
SP:SAMPLEPREP_SUMMARY            	injected at the beginning of each analytical run, followed by samples randomized
SP:SAMPLEPREP_SUMMARY            	independently. A QC sample was rerun after each block of 5 samples.
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_TYPE           	GC
CH:INSTRUMENT_NAME               	Agilent 7890A
CH:COLUMN_NAME                   	Agilent DB5-MS (30m x 0.25mm, 0.25um)
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Agilent 5975C
MS:INSTRUMENT_TYPE               	Single quadrupole
MS:MS_TYPE                       	EI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	None
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	area
MS_METABOLITE_DATA_START
Samples	Case_Plasma_GC	Control_Plasma_GC
Factors	Subject:Case	Subject:Control
oleic acid	192004	34107
L-(+) lactic acid	11826347	2117776
3-Hydroxybutyric acid	14884	79152
p-cresol	53004	10836
L-tryptophan	121711	30344
2-Hydroxy-3-methylbutyric acid	5209	19596
Propanoic acid	267915	76515
Asparagine	6539	1883
linoleic acid	42314	12647
glycerol	479290	152527
Pyranose	9632558	30186272
Furanose	9320	28048
Glyceric acid	7638	2570
urea	12002771	4061942
Alanine	995970	345286
L-glutamine	33676	11894
L-Lysine	12857	4776
Aminomalonic acid	31934	12183
tyrosine	155552	61473
citric acid	14529	6334
L-glutamic acid	33580	15077
palmitic acid	209222	107254
Myo-Inositol	53517	28179
phosphoric acid	840792	456766
Glycine	286499	159994
oxalic acid	2616	1514
Valine	710113	423326
L-Serine	174466	105774
L-threonine	99828	61661
2-ketoisocaproic acid	34128	21903
meso-Erythritol	6744	4398
Creatinine	37271	24804
DL-isoleucine	192207	280429
L-methionine	28408	21049
Phenylalanine	120124	89048
stearic acid	55374	45908
Methyl stearate	273257	236308
2-hydroxybutyric acid	98807	106100
L-proline	391737	365035
glycolic acid	3149	3346
L-pyroglutamic acid	203628	191868
L-leucine	511836	499602
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name
oleic acid
L-(+) lactic acid
3-Hydroxybutyric acid
p-cresol
L-tryptophan
2-Hydroxy-3-methylbutyric acid
Propanoic acid
Asparagine
linoleic acid
glycerol
Pyranose
Furanose
Glyceric acid
urea
Alanine
L-glutamine
L-Lysine
Aminomalonic acid
tyrosine
citric acid
L-glutamic acid
palmitic acid
Myo-Inositol
phosphoric acid
Glycine
oxalic acid
Valine
L-Serine
L-threonine
2-ketoisocaproic acid
meso-Erythritol
Creatinine
DL-isoleucine
L-methionine
Phenylalanine
stearic acid
Methyl stearate
2-hydroxybutyric acid
L-proline
glycolic acid
L-pyroglutamic acid
L-leucine
METABOLITES_END
#END